» Authors » J Kobashigawa

J Kobashigawa

Explore the profile of J Kobashigawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 712
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong E, Morris K, Sodhi G, Chang D, Czer L, Chung J, et al.
Transplant Proc . 2018 Dec; 50(10):4057-4061. PMID: 30577314
First described in the United States in the late 1990s, West Nile virus (WNV) infection following solid organ transplantation is a rare but life-threatening complication. The many ways in which...
2.
Patel S, Levin-Epstein R, Kobashigawa J
Transplant Proc . 2017 Aug; 49(7):1672-1674. PMID: 28784558
Background: The present study reports a case of piperacillin-induced thrombocytopenia in a dual heart and kidney transplant patient on January 28, 2016 (taking mycophenolate mofetil and tacrolimus). Before the transplant,...
3.
Levitsky J, Formica R, Bloom R, Charlton M, Curry M, Friedewald J, et al.
Am J Transplant . 2017 May; 17(11):2790-2802. PMID: 28556422
The availability of direct-acting antiviral agents for the treatment of hepatitis C virus (HCV) infection has resulted in a profound shift in the approach to the management of this infection....
4.
Kobashigawa J, Khush K, Colvin M, Acker M, Van Bakel A, Eisen H, et al.
Am J Transplant . 2017 May; 17(10):2559-2566. PMID: 28510318
Cardiac transplantation remains the only definitive treatment for end-stage heart failure. Transplantation rates are limited by a shortage of donor hearts. This shortage is magnified because many hearts are discarded...
5.
Arman D, Kuraitis D, Moriguchi J, Hamilton M, Liou F, Siddiqui S, et al.
Transplant Proc . 2016 Dec; 48(10):3393-3396. PMID: 27931587
Background: The use of mechanical circulatory support devices (MCSDs) has been increasing over the past several years. Driveline infections (DLIs) are one of the most common complications seen in these...
6.
Awad M, Czer L, Mirocha J, Ruzza A, De Robertis M, Rafiei M, et al.
Transplant Proc . 2016 Oct; 48(8):2782-2791. PMID: 27788818
Background: The upper age limit of heart transplantation remains controversial. The goal of the present study was to investigate the mortality and morbidity of orthotopic heart transplantation (HT) for recipients ...
7.
Ruzza A, Czer L, De Robertis M, Luthringer D, Moriguchi J, Kobashigawa J, et al.
Transplant Proc . 2016 Feb; 48(1):279-81. PMID: 26915885
Chagas disease (CD) is becoming an increasingly recognized cause of dilated cardiomyopathy outside of Latin America, where it is endemic, due to population shifts and migration. Heart transplantation (HTx) is...
8.
Awad M, Czer L, De Robertis M, Mirocha J, Ruzza A, Rafiei M, et al.
Transplant Proc . 2016 Feb; 48(1):158-66. PMID: 26915862
Purpose: The impact of prior implantation of a ventricular assist device (VAD) on short- and long-term postoperative outcomes of adult heart transplantation (HTx) was investigated. Methods: Of the 359 adults...
9.
Vertanous T, Czer L, De Robertis M, Kiankhooy A, Kobashigawa J, Esmailian F, et al.
Transplant Proc . 2016 Feb; 48(1):10-4. PMID: 26915835
Objective: The influence of new donor registrations through the California Organ and Tissue Donor Registry on the local OneLegacy Organ Procurement Organization (OPO) was examined during a 6-year period. Methods:...
10.
Reich H, Awad M, Ruzza A, De Robertis M, Ramzy D, Nissen N, et al.
Transplant Proc . 2015 Dec; 47(9):2722-6. PMID: 26680081
Purpose: Combined heart-liver transplantation is an increasingly accepted treatment for select patients with heart and liver disease. Despite growing optimism, heart-liver transplantation remains an infrequent operation. We report our institutional...